A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma - Regional Cancer Care Associates LLC

Clinical Trials

A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma
Locations
Bethesda
Sponsor
(Oprozomib) 20160104
Protocol Number
Cancer Diagnosis
To Learn More Call
201-510-0910